Effects of trans-endocardial delivery of bone marrow-derived CD133+ cells on angina and quality of life in patients with refractory angina: A sub-analysis of the REGENT-VSEL trial.
Jadczyk T, Ciosek J, Michalewska-Wludarczyk A, Szot W, Parma Z, Ochala B, Markiewicz M, Rychlik W, Kostkiewicz M, Gruszczynska K, Blach A, Dzierzak-Mietla M, Rzeszutko L, Partyka L, Zasada W, Smolka G, Pawlowski T, Jedrzejek M, Starek Z, Plens K, Ochala A, Tendera M, Wojakowski W.
Jadczyk T, et al. Among authors: pawlowski t.
Cardiol J. 2018;25(4):521-529. doi: 10.5603/CJ.2018.0082.
Cardiol J. 2018.
PMID: 30211929
Free article.
Clinical Trial.